selected scholarly activity
-
conferences
- Sex Differences in the Etiology and Burden of Heart Failure Across the Sociodemographic Index: Analysis of 204 Countries and Territories, 1990-2019. Circulation. 2022
- FACTORS ASSOCIATED WITH UNDER-ENROLMENT OF FEMALES IN CLINICAL TRIALS OF HEART FAILURE WITH REDUCED EJECTION FRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS. Journal of the American College of Cardiology. 1059-1059. 2020
- Clinical Characteristics of Patients With Heart Failure Show a Continuum Across the Spectrum of Left Ventricular Ejection Fraction: A Substudy of the Patient-Centered Care Transitions in Heart Failure Randomized Clinical Trial. Circulation. 2019
- A point-of-care risk score predicts 30-day readmission in patients hospitalized with heart failure (HF): derivation and validation of the LENT index. European Heart Journal. 3953-3953. 2019
- Intensity and cost of health care at the end of life among patients with heart failure. European Heart Journal. 1329-1329. 2019
- Sex-based disparities in end of life care among patients with heart failure. European Heart Journal. 2129-2129. 2019
- 98 Non-specific chest pain hospital admissions and readmissions for serious cardiovascular events in the United States. Heart. A82-A82. 2019
- Variations in Stepped Wedge Cluster Randomized Trial Design: Insights From the Patient-Centered Care Transitions in Heart Failure Trial. Circulation. 2018
- All you need is LE: utility of an abbreviated LACE score in predicting 30-day outcomes among patients hospitalized for Heart Failure (HF). European Heart Journal. 1397-1397. 2018
- Predicting risk at the point of care: NT-proBNP improves performance of the LACE index among patients hospitalized for Heart Failure (HF). European Heart Journal. 1038-1038. 2018
- Knowledge to Action: Rationale and Design of the Patient-Centred Care Transitions in Heart Failure (PACT-HF) Pragmatic Trial. Circulation. 2017
- EFFECTIVENESS OF IMPLEMENTATION INTERVENTIONS IN IMPROVING PHYSICIAN ADHERENCE TO GUIDELINE RECOMMENDATIONS IN HEART FAILURE: A SYSTEMATIC REVIEW. BMJ Open. 288-288. 2017
- PATIENT PERCEPTIONS ABOUT A HOSPITAL-AT-HOME MODEL OF CARE FOR DECOMPENSATED HEART FAILURE. Cardiology. 206-206. 2016
- UTILITY OF THE LACE INDEX AT THE BEDSIDE IN PREDICTING 30-DAY READMISSION OR DEATH IN PATIENTS HOSPITALIZED WITH HEART FAILURE. Cardiology. 428-428. 2016
- Comparative effectiveness of transitional care services in patients discharged from hospital with heart failure: a meta-analysis. European Heart Journal. 1202-1202. 2015
- COMPARATIVE EFFECTIVENESS OF TRANSITIONAL CARE SERVICES IN PATIENTS DISCHARGED FROM THE HOSPITAL WITH HEART FAILURE (HF): A META-ANALYSIS. Cardiology. 470-470. 2014
- Importance of algorithm-based warfarin dosing in the quality of anticoagulation control in atrial fibrillation - a multilevel analysis. European Heart Journal. 461-461. 2011
- Randomized comparison of the DAWN AC computer program and a simple manual nomogram for quality of warfarin dosing. Journal of Thrombosis and Haemostasis. 302-302. 2011
- UTILITY OF AN EMPIRICAL INITIAL TRIAGE RISK ASSESSMENT IN ACUTE HEART FAILURE (HF): ILLUSTRATION USING THE CANADIAN TRIAGE ACUITY SCALE. Canadian Journal of Cardiology. 113D-113D. 2010
-
journal articles
- Mineralocorticoid Antagonism in Heart Failure: Established and Emerging Therapeutic Role.. JACC: Heart Failure. 12:1979-1993. 2024
- A Guide to Implementation Science for Phase 3 Clinical Trialists: Designing Trials for Evidence Uptake.. Journal of the American College of Cardiology. 84:2063-2072. 2024
- Cardiovascular Care in Canada: Strengths, Challenges, and Opportunities For Improvement.. Circulation. 150:1490-1492. 2024
- Long-term clinical outcomes and healthcare resource utilization in male and female patients following hospitalization for heart failure.. European Journal of Heart Failure. 2024
- International Comparison of Quality Indicators for Adults Hospitalized for Heart Failure: A Systematic Review.. Circulation. Cardiovascular Quality and Outcomes. 17:e010629. 2024
- Advancing women's cardiovascular health: an international lens on the Joint British Cardiovascular Societies' consensus statement.. Heart. 110:1289-1290. 2024
- In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure.. Heart Failure Reviews. 1-13. 2024
- How to make cardiology clinical trials more inclusive.. Nature Medicine. 30:2745-2755. 2024
- Mitigating the risk of artificial intelligence bias in cardiovascular care.. The Lancet Digital Health. 6:e749-e754. 2024
- Barriers and facilitators to implementation of intravenous cardiovascular treatments in ambulatory settings.. ESC heart failure. 2024
- The Intersection of Socioeconomic Differences and Sex in the Management and Outcomes of Acute Myocardial Infarction: A Nationwide Cohort Study.. Angiology. 33197241273433. 2024
- 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures.. Journal of the American College of Cardiology. 84:1123-1143. 2024
- Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study. European Heart Journal - Quality of Care and Clinical Outcomes. 10:543-551. 2024
- From Hospital to Home. JACC: Advances. 3:101131-101131. 2024
- Prognostic value of quality of life and functional status in patients with heart failure: a systematic review and meta-analysis. Egyptian Heart Journal. 76:97. 2024
- A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Health-Related Quality-of-Life Instruments Part I: Instrument Development and Content Validity. Value in Health. 27:1130-1148. 2024
- Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure. JACC: Heart Failure. 12:1365-1377. 2024
- Journal requirement for data sharing statements in clinical trials: a cross-sectional study. Journal of Clinical Epidemiology. 172:111405-111405. 2024
- Is Investigator Sex Associated With Female Underenrollment in Arrhythmia Trials?. JACC: Clinical Electrophysiology. 10:1486-1488. 2024
- Addressing the Global Burden of Cardiovascular Disease in Women. Journal of the American College of Cardiology. 83:2690-2707. 2024
- Putting More Weight on Obesity Trials in Heart Failure. Current Heart Failure Reports. 21:194-202. 2024
-
Reporting quality of heart failure randomized controlled trials 2000–2020: Temporal trends in adherence to
CONSORT criteria. European Journal of Heart Failure. 26:1369-1380. 2024 - Role of telemedicine in the management of obesity: State‐of‐the‐art review. Obesity Reviews. 25:e13734. 2024
- Trends in ST-elevation myocardial infarction hospitalization among young adults: a binational analysis. European Heart Journal - Quality of Care and Clinical Outcomes. 10:216-227. 2024
- Association Between Remnant Cholesterol and Risk of Incident Atrial Fibrillation: Population‐Based Evidence From a Large‐Scale Prospective Cohort Study. Journal of the American Heart Association. 13:e033840. 2024
- Implementation Science to Achieve Equity in Heart Failure Care: A Scientific Statement From the American Heart Association. Circulation. 149:e1143-e1163. 2024
- Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive. Canadian Journal of Cardiology. 40:500-523. 2024
- Systematic Review of Women Leading and Participating in Nephrology Randomized Clinical Trials. Kidney International Reports. 9:898-906. 2024
- Validation of China Health-Related Outcomes Measures-Cardiovascular Disease. Value in Health. 27:490-499. 2024
- Effect of a transitional care model following hospitalization for heart failure: 3‐year outcomes of the Patient‐Centered Care Transitions in Heart Failure (PACT‐HF) randomized controlled trial. European Journal of Heart Failure. 26:652-660. 2024
- Heart Failure Risk Under Covers: Sleeping With the Enemy. Journal of Cardiac Failure. 30:449-451. 2024
- In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo. ACP journal club. 177:JC30-JC30. 2024
- Interventions to enhance digital health equity in cardiovascular care. Nature Medicine. 30:628-630. 2024
- Worth Their Weight? An Update on New and Emerging Pharmacologic Agents for Obesity and Their Potential Role for Persons with Cardiac Conditions. Current Cardiology Reports. 26:61-71. 2024
- 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 149:e347-e913. 2024
- Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction. Circulation. 149:510-520. 2024
- Heart Failure Readmission in Patients With ST-Segment Elevation Myocardial Infarction and Active Cancer. JACC: CardioOncology. 6:117-129. 2024
- Sex Differences in the Clinical Presentation and Natural History of Dilated Cardiomyopathy. JACC: Heart Failure. 12:352-363. 2024
- The Canadian Women’s Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 8: Knowledge Gaps and Status of Existing Research Programs in Canada. CJC OPEN. 6:220-257. 2024
- The role of early-phase trials and real-world evidence in drug development. Nature Cardiovascular Research. 3:110-117. 2024
- Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity. Circulation. Heart Failure. 17:e010453. 2024
- Regional variations in heart failure: a global perspective. Heart. 110:11-18. 2024
- Association between cancer, CHA2DS2VASc risk, and in-hospital ischaemic stroke in patients hospitalized for atrial fibrillation. European Heart Journal - Quality of Care and Clinical Outcomes. 9:749-757. 2023
- Endpoint adjudication in cardiovascular clinical trials. European Heart Journal. 44:4835-4846. 2023
- CWHHA ATLAS: EPIDEMIOLOGY, DIAGNOSIS AND MANAGEMENT OF CARDIOVASCULAR DISEASES IN WOMEN Chapter 9: Summary of Current Status, Challenges, Opportunities, and Recommendations. CJC OPEN. 6:258-278. 2023
- Rural and urban disparities in cardiovascular disease-related mortality in the USA over 20 years; have the trends been reversed by COVID-19?. Int J Cardiol Cardiovasc Risk Prev. 19:200202-200202. 2023
- Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–2019. European Heart Journal - Quality of Care and Clinical Outcomes. 9:662-672. 2023
- Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure. JACC: Heart Failure. 11:1507-1517. 2023
- Rapid, accurate publication and dissemination of clinical trial results: benefits and challenges. European Heart Journal. 44:4220-4229. 2023
- A scoping review of heart failure transitional care quality indicators and outcomes for use in clinical care and research. European Journal of Heart Failure. 25:1842-1848. 2023
- Associations of health-related quality of life with major adverse cardiovascular and cerebrovascular events for individuals with ischaemic heart disease: systematic review, meta-analysis and evidence mapping. Open Heart. 10:e002452-e002452. 2023
- Causes of Death Among Health Care Professionals in the United States. Population Health Management. 26:294-302. 2023
- Guideline-Recommended Therapy Following Hospitalization for Heart Failure. JACC: Heart Failure. 11:1333-1336. 2023
- Hospital at Home as a Treatment Strategy for Worsening Heart Failure. Circulation. Heart Failure. 16:e010456. 2023
- Pharmaco‐disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries. ESC heart failure. 10:3152-3163. 2023
- Prevalence and outcomes of type 2 myocardial infarction in patients with cancer: A retrospective analysis from the National Inpatient Sample dataset. International Journal of Cardiology. 389:131154-131154. 2023
- Racial and Ethnic Disparities in Ambulatory Heart Failure Ventricular Assist Device Implantation and Survival. JACC: Heart Failure. 11:1397-1407. 2023
- Racial Disparities in Obesity‐Related Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020. Journal of the American Heart Association. 12:e028409. 2023
-
Artificial intelligence and heart failure: A
state‐of‐the‐art review. European Journal of Heart Failure. 25:1507-1525. 2023 - SGLT2 inhibitors improved health status in Black and White patients with HF regardless of race. ACP journal club. 176:JC100-JC100. 2023
- Sex differences in long‐term outcomes following acute heart failure hospitalization: Findings from the Get With The Guidelines‐Heart Failure registry. European Journal of Heart Failure. 25:1544-1554. 2023
- Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus. European Heart Journal - Quality of Care and Clinical Outcomes. 9:537-545. 2023
- Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply. European Heart Journal - Quality of Care and Clinical Outcomes. 9:547-547. 2023
- Bridging Treatment Implementation Gaps in Patients With Heart Failure. Journal of the American College of Cardiology. 82:544-558. 2023
- In adults with HF, opioids do not reduce refractory breathlessness (low-certainty evidence). ACP journal club. 176:JC88-JC88. 2023
- Pregnant and lactating women should be included in clinical trials for cardiovascular disease. Nature Medicine. 29:1897-1899. 2023
- Trials using composite outcomes neglect the presence of competing risks: a methodological survey of cardiovascular studies. Journal of Clinical Epidemiology. 160:1-13. 2023
- Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk. JACC: Heart Failure. 11:825-835. 2023
- Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 17:102804-102804. 2023
- Multi-level implementation strategies to improve uptake of evidence-based therapies in heart failure. European Heart Journal. 44:2055-2058. 2023
- Cardiovascular mortality trends in patients with chronic kidney disease compared to the general population. Journal of Nephrology. 36:1489-1491. 2023
- Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials. European Heart Journal. 44:1890-1909. 2023
- Team-Based Virtual Nudges to Overcome Clinician Inertia in Guideline-Directed Medical Therapy for Heart Failure. Journal of the American College of Cardiology. 81:1694-1696. 2023
- Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials. Journal of Cardiac Failure. 29:425-433. 2023
- Patient‐reported outcome measures and patient engagement in heart failure clinical trials: multi‐stakeholder perspectives. European Journal of Heart Failure. 25:478-487. 2023
- Improving representativeness in trials: a call to action from the Global Cardiovascular Clinical Trialists Forum. European Heart Journal. 44:921-930. 2023
- CKD-Associated Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020. Kidney Medicine. 5:100597-100597. 2023
- Effectiveness of Telemedicine Services After Hospitalization for Heart Failure. JACC: Heart Failure. 11:207-210. 2023
- Predicting Risk of Cardiotoxic Effects in Breast Cancer: Are We There Yet?. JAMA network open. 6:e230577-e230577. 2023
- Remote Patient Monitoring for Patients with Heart Failure: Sex- and Race-based Disparities and Opportunities. Cardiac Failure Review. 9:e02. 2023
- The association between cancer diagnosis, care, and outcomes in 1 million patients hospitalized for acute pulmonary embolism. International Journal of Cardiology. 371:354-362. 2023
- Dear colleagues: enough with the men-only author panels. European Heart Journal, Supplement. 24:L53-L56. 2022
- Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019. European Heart Journal - Quality of Care and Clinical Outcomes. 9:54-63. 2022
- Urban–rural disparities in diabetes-related mortality in the USA 1999–2019. Diabetologia. 65:2078-2083. 2022
- Palliative Care Utilization Among Hospitalized Patients With Common Chronic Conditions in the United States. Journal of Palliative Care. 082585972211367-082585972211367. 2022
- Performance of current risk stratification models for predicting mortality in patients with heart failure: a systematic review and meta-analysis. European Journal of Preventive Cardiology (EJPC). 29:2027-2048. 2022
- The need for increased pragmatism in cardiovascular clinical trials. Nature Reviews Cardiology. 19:737-750. 2022
- Trends in Heart Failure–Related Mortality Among Older Adults in the United States From 1999-2019. JACC: Heart Failure. 10:851-859. 2022
- Utilization of Implantable Cardioverter Defibrillators Among Patients with a Left Ventricular Assist Device: Insights From a National Database. Current Problems in Cardiology. 47:101334-101334. 2022
- Impact of cancer diagnosis on distribution and trends of cardiovascular hospitalizations in the USA between 2004 and 2017. European Heart Journal - Quality of Care and Clinical Outcomes. 8:787-797. 2022
- Urinary sodium: worth its salt?. European Heart Journal - Quality of Care and Clinical Outcomes. 8:701-702. 2022
- A Systematic Review of Sex-Specific Reporting in Heart Failure Clinical Trials. JACC: Advances. 1:100079-100079. 2022
- In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status. ACP journal club. 175:JC111-JC111. 2022
- Patient-Reported Outcome Measures in Cardiovascular Disease: An Evidence Map of the Psychometric Properties of Health Status Instruments. ACP journal club. 175:1431-1439. 2022
- Representation of women in heart failure trials: does it matter?. Heart. 108:1508-1509. 2022
- Twenty-year trends in racial and ethnic enrollment in large diabetes randomized controlled trials. BMC Medicine. 20:294. 2022
- Global representation of heart failure clinical trial leaders, collaborators, and enrolled participants: a bibliometric review 2000–20. European Heart Journal - Quality of Care and Clinical Outcomes. 8:659-669. 2022
- Can We Stop Reflexively Discontinuing Mineralocorticoid Antagonists for Patients With Heart Failure and Hyperkalemia?. Journal of Cardiac Failure. 28:1464-1468. 2022
- Distinct pathophysiological pathways in women and men with heart failure. European Journal of Heart Failure. 24:1532-1544. 2022
- Exploring ethnic representativeness in diabetes clinical trial enrolment from 2000 to 2020: a chronological survey. Diabetologia. 65:1461-1472. 2022
- Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management. Heart. 108:1342-1350. 2022
- Relationships between 2018 UNOS heart policy and transplant outcomes in metropolitan, micropolitan, and rural settings. The Journal of Heart and Lung Transplantation. 41:1228-1236. 2022
- The collateral damage of COVID-19 to cardiovascular services: a meta-analysis. European Heart Journal. 43:3164-3178. 2022
- Women Are Less Likely to Survive AMI Presenting With Out-of-Hospital Cardiac Arrest. Mayo Clinic proceedings. 97:1608-1618. 2022
- Association of admitting physician specialty and care quality and outcomes in non-ST-segment elevation myocardial infarction (NSTEMI): insights from a national registry. European Heart Journal - Quality of Care and Clinical Outcomes. 8:557-567. 2022
- Ethnic disparities in care and outcomes of non-ST-segment elevation myocardial infarction: a nationwide cohort study. European Heart Journal - Quality of Care and Clinical Outcomes. 8:518-528. 2022
- Racial and Socioeconomic Disparities in Cardiovascular Outcomes of Preeclampsia Hospitalizations in the United States 2004-2019. JACC: Advances. 1:100062-100062. 2022
- Enrollment of Black, Indigenous, and Other People of Color in Multicountry Randomized Controlled Trials of Diabetes Conducted in North America and Europe. Diabetes Care. 45:e116-e117. 2022
- Applications of artificial intelligence and machine learning in heart failure. European Heart Journal - Digital Health. 3:311-322. 2022
- Incorporating Cultural Competence and Cultural Humility in Cardiovascular Clinical Trials to Increase Diversity Among Participants. Journal of the American College of Cardiology. 80:89-92. 2022
- Relation of Extracardiac Vascular Disease and Outcomes in Patients With Diabetes (1.1 Million) Hospitalized for Acute Myocardial Infarction. American Journal of Cardiology. 175:8-18. 2022
- The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment. CJC OPEN. 4:589-608. 2022
- Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study. European Heart Journal. 43:2289-2299. 2022
- Real-world management and outcomes of 7 million patients with acute coronary syndrome according to clinical research trial enrolment status: a propensity matched analysis. European Heart Journal - Quality of Care and Clinical Outcomes. 8:409-419. 2022
- Emerging Implantable-Device Technology for Patients at the Intersection of Electrophysiology and Heart Failure Interdisciplinary Care. Journal of Cardiac Failure. 28:991-1015. 2022
- In HF with mitral regurgitation, adding transcatheter mitral valve repair to medical therapy improved renal outcomes at 2 y. ACP journal club. 175:JC65-JC65. 2022
- Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?. Thrombosis and Haemostasis. 122:871-878. 2022
- Underutilization of Guideline-Directed Medical Therapy in Heart Failure. Journal of the American College of Cardiology. 79:2214-2218. 2022
- Meta-Analysis of Nonalcoholic Fatty Liver Disease and Incident Heart Failure. American Journal of Cardiology. 171:180-181. 2022
- The Association Between Socioeconomic Status, Sex, Race / Ethnicity and In-Hospital Mortality Among Patients Hospitalized for Heart Failure. Journal of Cardiac Failure. 28:697-709. 2022
- The underrepresentation of female athletes in sports research: considerations for cardiovascular health. European Heart Journal. 43:1609-1611. 2022
- Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018. JACC: Heart Failure. 10:350-362. 2022
- Trends in National Institutes of Health R01 Funding of Principal Investigators in Cardiology by Gender. Journal of the American College of Cardiology. 79:1544-1546. 2022
- Management and outcomes of acute myocardial infarction in patients with preexisting heart failure: an analysis of 2 million patients from the national inpatient sample. Expert Review of Cardiovascular Therapy. 20:233-240. 2022
- Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease. Circulation. 145:693-712. 2022
- Factors Associated With Racial and Ethnic Diversity Among Heart Failure Trial Participants: A Systematic Bibliometric Review. Circulation. Heart Failure. 15:e008685. 2022
- The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 5: Sex- and Gender-Unique Manifestations of Cardiovascular Disease. CJC OPEN. 4:243-262. 2022
- The Hospital at Home Model vs Routine Hospitalization for Acute Heart Failure: A Survey of Patients’ Preferences. CJC OPEN. 4:263-270. 2022
- Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study. PLoS Medicine. 19:e1003904-e1003904. 2022
- Contemporary Review of Hemodynamic Monitoring in the Critical Care Setting. US Cardiology Review. 16:e12. 2022
- Frailty Among Patients With Acute ST-Elevation Myocardial Infarction in the United States: The Impact of the Primary Percutaneous Coronary Intervention on In-Hospital Outcomes. Journal of Invasive Cardiology. 34:E55-E64. 2022
- Protection by inclusion: Increasing enrollment of women in cardiovascular trials. Am Heart J Plus. 13:100091-100091. 2022
- The Impact of Charlson Comorbidity Index on De Novo Cardiac Implantable Electronic Device Procedural Outcomes in the United States. Mayo Clinic proceedings. 97:88-100. 2022
- Why is it important for male cardiologists to enroll more women in cardiovascular trials?. Am Heart J Plus. 13:100090-100090. 2022
- Corrigendum to: Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis. European Heart Journal: Acute Cardiovascular Care. 10:1101-1101. 2021
- Assessment of an Interactive Digital Health–Based Self-management Program to Reduce Hospitalizations Among Patients With Multiple Chronic Diseases. JAMA network open. 4:e2140591-e2140591. 2021
- National Trends of Gender Disparity in Canadian Cardiovascular Society Guideline Authors, 2001-2020. CJC OPEN. 3:S12-S18. 2021
- Trends of Sex Differences in Clinical Outcomes After Myocardial Infarction in the United States. CJC OPEN. 3:S19-S27. 2021
- Temporal Trends and Factors Associated With the Inclusion of Patient‐Reported Outcomes in Heart Failure Randomized Controlled Trials: A Systematic Review. Journal of the American Heart Association. 10:e022353. 2021
- Bias: does it account for low surgical rates in women with infective endocarditis?. Heart. 107:1688-1689. 2021
- Predictors, Treatments, and Outcomes of Do-Not-Resuscitate Status in Acute Myocardial Infarction Patients (from a Nationwide Inpatient Cohort Study). American Journal of Cardiology. 159:8-18. 2021
- Sex-Specific Clinical Outcomes of the PACT-HF Randomized Trial. Circulation. Heart Failure. 14:e008548. 2021
- Trends in cardiovascular mortality of cancer patients in the US over two decades 1999‐2019. International Journal of Clinical Practice. 75:e14841. 2021
- Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis. European Heart Journal: Acute Cardiovascular Care. 10:829-839. 2021
- Distribution, management and outcomes of AMI according to principal diagnosis priority during inpatient admission. International Journal of Clinical Practice. 75:e14554. 2021
- Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions. International Journal of Cardiology. 341:76-83. 2021
- Treatment Effect of Percutaneous Coronary Intervention in Men Versus Women With ST‐Segment–Elevation Myocardial Infarction. Journal of the American Heart Association. 10:e021638. 2021
-
Effect of patient‐centered transitional care services on patient‐reported outcomes in heart failure: sex‐specific analysis of the
PACT‐HF randomized controlled trial. European Journal of Heart Failure. 23:1488-1498. 2021 - Risk and risk reduction in trials of heart failure with reduced ejection fraction: absolute or relative?. European Journal of Heart Failure. 23:1437-1444. 2021
- Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes. ESC heart failure. 8:2741-2754. 2021
- Derivation and validation of a two‐variable index to predict 30‐day outcomes following heart failure hospitalization. ESC heart failure. 8:2690-2697. 2021
- Excess deaths from COVID-19 and other causes by region, neighbourhood deprivation level and place of death during the first 30 weeks of the pandemic in England and Wales: A retrospective registry study. The Lancet Regional Health - Europe. 7:100144-100144. 2021
- Increasing representation and diversity in cardiovascular clinical trial populations. Nature Reviews Cardiology. 18:537-538. 2021
- Temporal Trends and Clinical Trial Characteristics Associated With the Inclusion of Women in Heart Failure Trial Steering Committees: A Systematic Review. Circulation. Heart Failure. 14:e008064. 2021
- Exclusion of pregnant and lactating women from COVID-19 vaccine trials: a missed opportunity. European Heart Journal. 42:2724-2726. 2021
- Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic. European Heart Journal - Quality of Care and Clinical Outcomes. 7:378-387. 2021
- Is it Time for Sex-Specific Guidelines for Cardiovascular Disease?. Journal of the American College of Cardiology. 78:189-192. 2021
- Systematic review of academic bullying in medical settings: dynamics and consequences. BMJ Open. 11:e043256-e043256. 2021
- Ending Gender Inequality in Cardiovascular Clinical Trial Leadership. Journal of the American College of Cardiology. 77:2960-2972. 2021
- In HFrEF, adding empagliflozin to medical therapy reduced a composite outcome, regardless of CKD status. ACP journal club. 174:JC68-JC68. 2021
- The Use of SMS Text Messaging to Improve the Hospital-to-Community Transition in Patients With Acute Coronary Syndrome (Txt2Prevent): Results From a Pilot Randomized Controlled Trial. JMIR mHealth and uHealth. 9:e24530-e24530. 2021
- Social Media in Heart Failure: A Mixed-Methods Systematic Review. Current Cardiology Reviews. 17:161-170. 2021
- Barriers and facilitators of the uptake of digital health technology in cardiovascular care: a systematic scoping review. European Heart Journal - Digital Health. 2:62-74. 2021
- Improving Health-Related Quality of Life for Women With Acute Heart Failure. JACC: Heart Failure. 9:346-348. 2021
- CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction. Canadian Journal of Cardiology. 37:531-546. 2021
- Cost of inpatient heart failure care and 30-day readmissions in the United States. International Journal of Cardiology. 329:115-122. 2021
- In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y. ACP journal club. 174:JC45-JC45. 2021
- Location of death among patients presenting with cardiovascular disease to the emergency department in the United states. International Journal of Clinical Practice. 75:e13798. 2021
- Sex-Specific Differences in Heart Failure: Pathophysiology, Risk Factors, Management, and Outcomes. Canadian Journal of Cardiology. 37:560-571. 2021
- Medical publishing under review. European Heart Journal. 42:723-725. 2021
- The LENT index predicts 30 day outcomes following hospitalization for heart failure. ESC heart failure. 8:518-526. 2021
- Mobile health applications for the detection of atrial fibrillation: a systematic review. Europace. 23:11-28. 2021
- Temporal Trends and Sex Differences in Intensity of Healthcare at the End of Life in Adults With Heart Failure. Journal of the American Heart Association. 10:e018495. 2021
- Sex Disparities in the Choice of Cardiac Resynchronization Therapy Device: An Analysis of Trends, Predictors, and Outcomes. Canadian Journal of Cardiology. 37:86-93. 2021
- Trial characteristics associated with under‐enrolment of females in randomized controlled trials of heart failure with reduced ejection fraction: a systematic review. European Journal of Heart Failure. 23:15-24. 2021
- Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors. Journal of the American College of Cardiology. 76:1919-1930. 2020
- COVID-19 and Katrina: recalcitrant racial disparities. European Heart Journal. 41:3390-3393. 2020
- Vericiguat reduced a composite of CV death or HF hospitalization in patients with HF and reduced LVEF. ACP journal club. 173:JC30-JC30. 2020
- Applications of digital technology in COVID-19 pandemic planning and response. The Lancet Digital Health. 2:e435-e440. 2020
- Socioeconomic Status and Differences in the Management and Outcomes of 6.6 Million US Patients With Acute Myocardial Infarction. American Journal of Cardiology. 129:10-18. 2020
- Optimizing Access to Heart Failure Care in Canada During the COVID-19 Pandemic. Canadian Journal of Cardiology. 36:1148-1151. 2020
- Pooled RCTs: In patients with HF in sinus rhythm, β-blockers reduced mortality at GFR ≥ 30 mL/min/1.73 m2. ACP journal club. 172:JC38-JC38. 2020
- Cardiogenic Shock in the Setting of Acute Myocardial Infarction. Circulation: Cardiovascular Interventions. 13:e009034. 2020
- Sex differences in rates and causes of 30-day readmissions after cardiac electronic device implantations: insights from the Nationwide Readmissions Database. International Journal of Cardiology. 302:67-74. 2020
- Dapagliflozin reduced worsening HF or CV death in HF with reduced ejection fraction. ACP journal club. 172:JC16-JC16. 2020
- State of the Science in Women's Cardiovascular Disease: A Canadian Perspective on the Influence of Sex and Gender. Journal of the American Heart Association. 9:e015634. 2020
- The Hospital Frailty Risk Score and its association with in-hospital mortality, cost, length of stay and discharge location in patients with heart failure short running title: Frailty and outcomes in heart failure. International Journal of Cardiology. 300:184-190. 2020
- Variations in stepped-wedge cluster randomized trial design: Insights from the Patient-Centered Care Transitions in Heart Failure trial. American Heart Journal. 220:116-126. 2020
- Flattening the hierarchies in academic medicine: the importance of diversity in leadership, contribution, and thought. European Heart Journal. 41:9-10. 2020
- Transitional care quality indicators to assess quality of care following hospitalisation for chronic obstructive pulmonary disease and heart failure: a systematic review protocol. BMJ Open. 9:e032764-e032764. 2019
- Relation of Frailty to Outcomes in Patients With Acute Coronary Syndromes. American Journal of Cardiology. 124:1002-1011. 2019
- Early Unplanned Readmissions After Admission to Hospital With Heart Failure. American Journal of Cardiology. 124:736-745. 2019
- Machine Learning Could Facilitate Optimal Titration of Guideline-Directed Medical Therapy in Heart Failure. Journal of the American College of Cardiology. 74:1424-1425. 2019
- Non-specific chest pain and subsequent serious cardiovascular readmissions. International Journal of Cardiology. 291:1-7. 2019
- Readmission and processes of care across weekend and weekday hospitalisation for acute myocardial infarction, heart failure or stroke: an observational study of the National Readmission Database. BMJ Open. 9:e029667-e029667. 2019
- In patients with previous dilated cardiomyopathy, withdrawal of HF drugs increased relapse at 6 months. ACP journal club. 170:JC28-JC28. 2019
- Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure. Journal of the American Medical Association (JAMA). 321:753-753. 2019
- A wearable cardioverter–defibrillator did not reduce arrhythmic death in MI with reduced ejection fraction. ACP journal club. 170:JC5-JC5. 2019
- A review of interventions to improve clinical outcomes following hospitalisation for heart failure. Kardiologia Polska. 77:341-346. 2019
- Moving knowledge into action for more effective practice, programmes and policy: protocol for a research programme on integrated knowledge translation. Implementation Science. 13:22. 2018
- Knowledge to action: Rationale and design of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) stepped wedge cluster randomized trial. American Heart Journal. 199:75-82. 2018
- Effectiveness of implementation interventions in improving physician adherence to guideline recommendations in heart failure: a systematic review. BMJ Open. 8:e017765-e017765. 2018
- Review: In HF with preserved EF, β-blockers reduced mortality; drug treatment overall did not. ACP journal club. 167:JC68-JC68. 2017
- Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta‐analysis. European Journal of Heart Failure. 19:1427-1443. 2017
- The Use of Text Messaging to Improve the Hospital-to-Community Transition in Acute Coronary Syndrome Patients (Txt2Prevent): Intervention Development and Pilot Randomized Controlled Trial Protocol. JMIR Research Protocols. 6:e91-e91. 2017
- Utility of the LACE index at the bedside in predicting 30-day readmission or death in patients hospitalized with heart failure. American Heart Journal. 179:51-58. 2016
- Transition care with telemonitoring did not reduce readmission after hospitalization for heart failure. ACP journal club. 164:JC59-JC59. 2016
- Effectiveness of implementation strategies in improving physician adherence to guideline recommendations in heart failure: a systematic review protocol. BMJ Open. 6:e009364-e009364. 2016
- Near-misses are an opportunity to improve patient safety. Current Opinion in Otolaryngology and Head and Neck Surgery. 23:292-296. 2015
- Hypoplasia of the posterior mitral valve leaflet detected in late adulthood. European Heart Journal. 36:456-456. 2015
- Efficacy of Hospital at Home in Patients with Heart Failure: A Systematic Review and Meta-Analysis. PLoS ONE. 10:e0129282-e0129282. 2015
- Review: Natriuretic peptide–guided therapy reduces mortality more than clinically guided therapy in heart failure. ACP journal club. 161:JC10-JC10. 2014
- Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices. Journal of Thrombosis and Thrombolysis. 37:435-442. 2014
- Accelerated care versus standard care among patients with hip fracture: the HIP ATTACK pilot trial. CANADIAN MEDICAL ASSOCIATION JOURNAL. 186:E52-E60. 2014
- Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. The BMJ. 346:f657-f657. 2013
- Commentary. Annals of Internal Medicine. 158. 2013
- Review: Case management reduces mortality and HF readmissions in patients with HF. ACP journal club. 158:JC11-JC11. 2013
- Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries. Circulation. 126:2309-2316. 2012
- Strain, Strain Rate, and the Force Frequency Relationship in Patients with and without Heart Failure. Journal of the American Society of Echocardiography. 25:341-348. 2012
- Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy. Thrombosis and Haemostasis. 108:1228-1235. 2012
- Prediction of Emergent Heart Failure Death by Semi-Quantitative Triage Risk Stratification. PLoS ONE. 6:e23065-e23065. 2011
- Report Cards for Cardiac Care. Journal of the American Medical Association (JAMA). 303:1367-1367. 2010
- A young man with deep vein thrombosis, hyperhomocysteinemia and cobalamin deficiency. CANADIAN MEDICAL ASSOCIATION JOURNAL. 178:279-281. 2008
- Inpatient smoking-cessation counseling and all-cause mortality in patients with acute myocardial infarction. American Heart Journal. 154:213-220. 2007
- Not a broken heart. The Lancet. 370:628-628. 2007
- Eligibility Criteria of Randomized Controlled Trials—Reply. Journal of the American Medical Association (JAMA). 298:37-37. 2007
- Eligibility criteria of randomized controlled trials - Reply [6]. Journal of the American Medical Association (JAMA). 298:39-40. 2007
- When My Father Died. ACP journal club. 146:893-893. 2007
- Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals. Journal of the American Medical Association (JAMA). 297:1233-1233. 2007
- Coronary vasospasm: a case report and review of the literature.. Canadian Journal of Cardiology. 21:953-957. 2005
- Is there a greater risk of dying in a car crash when other passengers are unrestrained?. CANADIAN MEDICAL ASSOCIATION JOURNAL. 170:1793-1793. 2004